These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6808133)

  • 21. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
    Casey FB; Abboa-Offei BE; Marretta J
    J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R; Kazimierczak W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiallergic activity of N-[4-(4-diphenylmethyl-1-piperazinyl)butyl]-1,4-dihydro-4-oxopyridine-3 - carboxamides.
    Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H; Matsumoto J
    Chem Pharm Bull (Tokyo); 1989 May; 37(5):1256-9. PubMed ID: 2483534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acrylamide derivatives as antiallergic agents. 2. Synthesis and structure-activity relationships of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(3-pyridyl)acryl amides.
    Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H
    J Med Chem; 1989 Mar; 32(3):583-93. PubMed ID: 2465410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of rat passive cutaneous anaphylaxis by 3-(tetrazol-5-yl)quinolines.
    Erickson EH; Hainline CF; Lenon LS; Matson CJ; Rice TK; Swingle KE; Van Winkle M
    J Med Chem; 1979 Jul; 22(7):816-23. PubMed ID: 109613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of predosage with disodium cromoglycate (DSCG) on the dose-related inhibition of rat passive cutaneous anaphylaxis by DSCG.
    Riley PA; Sheard P; Clarke AJ; Orr TS
    Life Sci; 1975 Sep; 17(5):793-802. PubMed ID: 813078
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and antiallergy activity of 4-(diarylhydroxymethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Walsh DA; Franzyshen SK; Yanni JM
    J Med Chem; 1989 Jan; 32(1):105-18. PubMed ID: 2562852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of different drugs in two models of immediate hypersensitivity.
    Ayala LE; Aleixandre MA; García Mora L
    J Pharm Pharmacol; 1988 Mar; 40(3):188-91. PubMed ID: 2899148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone sodium salt (MDL 427): a new antiallergic agent.
    Peet NP; Baugh LE; Sunder S; Lewis JE; Matthews EH; Olberding EL; Shah DN
    J Med Chem; 1986 Nov; 29(11):2403-9. PubMed ID: 2431144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on type I allergic reactions.
    Kohno SW; Murata T; Kinoshita T; Ohata K
    Arzneimittelforschung; 1986 Nov; 36(11):1619-27. PubMed ID: 2434110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents.
    Musser JH; Brown RE; Loev B; Bailey K; Jones H; Kahen R; Huang FC; Khandwala A; Leibowitz M; Sonnino-Goldman P
    J Med Chem; 1984 Feb; 27(2):121-5. PubMed ID: 6198518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by drugs of passive cutaneous anaphylaxis-induced skin histamine decrease.
    Yokoyama H; Shimamura K; Saeki K
    Acta Med Okayama; 1984 Aug; 38(4):357-65. PubMed ID: 6208752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on antiallergy agents. III. Synthesis of 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acids and related compounds.
    Ozeki K; Ichikawa T; Takehara H; Tanimura K; Sato M; Yaginuma H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1780-7. PubMed ID: 2572333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6,8-Di-t-butyl-4-oxo-4H-1-benzopyran-2-carboxylic acid: a chromone derivative with anti-allergic, anti-inflammatory and uricosuric activity.
    Augstein J; Cairns H; Chambers A; Burns JW; Radziwonik H
    J Pharm Pharmacol; 1976 Dec; 28(12):919-20. PubMed ID: 12270
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of allergic reactions by a novel phenanthroline ICI 74,917.
    Evans DP; Gilman DJ; Thomson DS; Waring WS
    Nature; 1974 Aug; 250(467):592-3. PubMed ID: 4136035
    [No Abstract]   [Full Text] [Related]  

  • 37. The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy.
    Church MK; Gradidge CF
    Br J Pharmacol; 1980 Oct; 70(2):307-11. PubMed ID: 6159030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiallergic agents. 3. N-(1H-tetrazol-5-yl)-2-pyridinecarboxamides.
    Honma Y; Hanamoto K; Hashiyama T; Sekine Y; Takeda M; Ono Y; Tsuzurahara K
    J Med Chem; 1984 Feb; 27(2):125-8. PubMed ID: 6229634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the antiallergic drug disodium cromoglycate and various derivatives on alkaline phosphatase.
    Ochoa de Aspuru E; Lourdes Zatón AM
    J Enzyme Inhib; 1994; 8(2):87-95. PubMed ID: 7539075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.